387 related articles for article (PubMed ID: 8230414)
1. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.
Kirnbauer R; Taub J; Greenstone H; Roden R; Dürst M; Gissmann L; Lowy DR; Schiller JT
J Virol; 1993 Dec; 67(12):6929-36. PubMed ID: 8230414
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
Heino P; Dillner J; Schwartz S
Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535
[TBL] [Abstract][Full Text] [Related]
3. Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products.
Wang M; Wang LL; Chen LF; Han YH; Zou YH; Si JY; Song GX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):27-34. PubMed ID: 12518224
[TBL] [Abstract][Full Text] [Related]
4. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
Kirnbauer R; Booy F; Cheng N; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12180-4. PubMed ID: 1334560
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.
Sasagawa T; Pushko P; Steers G; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L; Tommasino M
Virology; 1995 Jan; 206(1):126-35. PubMed ID: 7831768
[TBL] [Abstract][Full Text] [Related]
6. Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines.
Schellenbacher C; Roden R; Kirnbauer R
J Virol; 2009 Oct; 83(19):10085-95. PubMed ID: 19640991
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence.
Zhou J; Sun XY; Louis K; Frazer IH
J Virol; 1994 Feb; 68(2):619-25. PubMed ID: 8289365
[TBL] [Abstract][Full Text] [Related]
8. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
[TBL] [Abstract][Full Text] [Related]
9. L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.
Okun MM; Day PM; Greenstone HL; Booy FP; Lowy DR; Schiller JT; Roden RB
J Virol; 2001 May; 75(9):4332-42. PubMed ID: 11287582
[TBL] [Abstract][Full Text] [Related]
10. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
Huber B; Schellenbacher C; Shafti-Keramat S; Jindra C; Christensen N; Kirnbauer R
PLoS One; 2017; 12(1):e0169533. PubMed ID: 28056100
[TBL] [Abstract][Full Text] [Related]
11. Interactions between papillomavirus L1 and L2 capsid proteins.
Finnen RL; Erickson KD; Chen XS; Garcea RL
J Virol; 2003 Apr; 77(8):4818-26. PubMed ID: 12663788
[TBL] [Abstract][Full Text] [Related]
12. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
Roden RB; Greenstone HL; Kirnbauer R; Booy FP; Jessie J; Lowy DR; Schiller JT
J Virol; 1996 Sep; 70(9):5875-83. PubMed ID: 8709207
[TBL] [Abstract][Full Text] [Related]
13. [Expression of baculovirus recombinant HPV16L1 and L2 capsid proteins in insect cells].
Wei L; Han L; Ren J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):309-13. PubMed ID: 11986712
[TBL] [Abstract][Full Text] [Related]
14. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
15. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.
Greenstone HL; Nieland JD; de Visser KE; De Bruijn ML; Kirnbauer R; Roden RB; Lowy DR; Kast WM; Schiller JT
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1800-5. PubMed ID: 9465097
[TBL] [Abstract][Full Text] [Related]
16. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.
Rose RC; Bonnez W; Reichman RC; Garcea RL
J Virol; 1993 Apr; 67(4):1936-44. PubMed ID: 8383219
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses.
Park DS; Selvey LA; Kelsall SR; Frazer IH
J Virol Methods; 1993 Dec; 45(3):303-18. PubMed ID: 8106603
[TBL] [Abstract][Full Text] [Related]
18. Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.
Wakabayashi MT; Da Silva DM; Potkul RK; Kast WM
Intervirology; 2002; 45(4-6):300-7. PubMed ID: 12566713
[TBL] [Abstract][Full Text] [Related]
19. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
